AbbVie Inc. (NYSE:ABBV)

The period under review demonstrates significant fluctuations in economic profit. Net operating profit after taxes (NOPAT) decreased substantially from 2021 to 2023, before beginning a recovery in 2024 and 2025. Simultaneously, the cost of capital exhibited a consistent, albeit gradual, increase throughout the entire period. Invested capital experienced a decline from 2021 to 2023, followed by a slight increase in 2024, and a further decrease in 2025.

Economic Profit Trend

Economic profit peaked in 2021 at US$5,036 million and remained relatively high in 2022 at US$4,851 million. A marked shift occurred in 2023, with economic profit turning negative at -US$2,389 million. This negative trend continued into 2024, although the loss was reduced to -US$1,239 million. By 2025, economic profit had returned to positive territory, reaching US$708 million, indicating a potential turnaround.

NOPAT and Cost of Capital Relationship

The decline in NOPAT from 2021 to 2023 coincided with a rising cost of capital. This combination exerted downward pressure on economic profit. While NOPAT began to recover in 2024 and 2025, the continued increase in the cost of capital partially offset these gains. The increasing cost of capital suggests a potentially higher risk profile or changing market conditions impacting funding costs.

Invested Capital Impact

The reduction in invested capital from 2021 to 2023 may reflect strategic divestitures, asset sales, or improved capital efficiency. However, the negative economic profit during this period suggests that the reduction in invested capital did not fully compensate for the decline in NOPAT and the increase in the cost of capital. The slight increase in invested capital in 2024 did not prevent a continued negative economic profit, and the subsequent decrease in 2025 requires further investigation to determine its impact on future performance.

Overall, the period was characterized by a challenging environment for value creation, as evidenced by the shift to negative economic profit in 2023 and 2024. The recovery observed in 2025, while positive, is from a low base and warrants continued monitoring to assess its sustainability.

Net earnings attributable to AbbVie Inc. exhibited an initial increase from 2021 to 2022, followed by a substantial decline in 2023 and a slight recovery in 2024 and 2025. However, the trend in net operating profit after taxes (NOPAT) presents a different pattern. NOPAT decreased from 2021 to 2023, then increased significantly in 2024 and 2025.

NOPAT Trend

NOPAT began at US$12,362 million in 2021, decreasing to US$11,543 million in 2022, representing a decline of approximately 6.7%. A more pronounced decrease occurred in 2023, with NOPAT falling to US$3,292 million. This represents a substantial reduction of over 71% from the 2022 value. A recovery is then observed in 2024, with NOPAT rising to US$4,563 million, and continuing upward in 2025 to reach US$5,919 million. The 2025 value, while representing a significant improvement from 2023, remains below the levels seen in 2021 and 2022.

The divergence between the trends in net earnings and NOPAT suggests potential shifts in the company’s capital structure or non-operating items. While net earnings decreased significantly in 2023, the NOPAT decline was even more substantial, indicating that factors beyond core operating profitability contributed to the reduction in net income. The subsequent recovery in NOPAT, exceeding the recovery in net earnings, suggests improvements in operational efficiency or changes in the cost of capital may be influencing the results.

Relationship between NOPAT and Net Earnings

In 2021 and 2022, NOPAT was consistently higher than net earnings attributable to AbbVie Inc. However, this relationship changed in 2023 and 2024, where net earnings exceeded NOPAT. By 2025, net earnings and NOPAT were relatively close, but net earnings remained slightly higher. This difference could be attributed to items such as interest expense, taxes, and other non-operating income or expenses.

The substantial fluctuations in NOPAT warrant further investigation to understand the underlying drivers. A detailed analysis of the components of NOPAT, including operating revenue, operating expenses, and tax rates, would be necessary to pinpoint the specific factors contributing to these changes.

The reported income tax expense and cash operating taxes exhibit distinct trends over the five-year period. Income tax expense fluctuates considerably, while cash operating taxes generally increase, though with notable variations.

Income Tax Expense

Income tax expense increased from US$1,440 million in 2021 to US$1,632 million in 2022, representing a rise of approximately 13.3%. A subsequent decrease was observed in 2023, with expense falling to US$1,377 million. A significant shift occurred in 2024, resulting in a tax benefit of US$570 million. This was followed by a substantial increase in expense to US$2,364 million in 2025. The volatility suggests potential impacts from changes in tax laws, deferred tax asset adjustments, or significant shifts in pre-tax income.

Cash Operating Taxes

Cash operating taxes demonstrate an overall upward trend, although not consistently. The amount rose from US$2,843 million in 2021 to US$3,997 million in 2022, an increase of approximately 40.6%. Further growth was seen in 2023, reaching US$4,625 million. A considerable decline occurred in 2024, with cash taxes decreasing to US$1,339 million. The final year, 2025, shows a recovery to US$3,414 million. The fluctuations in cash taxes are likely influenced by timing differences between income tax expense and actual cash payments, as well as potential tax planning strategies.

Relationship between Income Tax Expense and Cash Operating Taxes

A divergence is apparent between the two measures. While income tax expense is reported on the income statement based on accounting standards, cash operating taxes reflect the actual cash outflows for taxes. The significant difference in 2024, where an income tax benefit is recorded alongside a cash outflow, indicates substantial deferred tax impacts or tax credits being utilized. The generally higher level of cash taxes compared to income tax expense throughout the period suggests the company may be utilizing tax loss carryforwards or experiencing temporary differences that result in higher cash payments than reported expense.

The observed patterns warrant further investigation into the underlying drivers of these fluctuations, particularly the significant changes in 2024 and 2025, to fully understand their implications for the company’s financial position and future cash flows.

The reported invested capital demonstrates a declining trend over the five-year period. Total reported debt & leases and stockholders’ equity both contribute to the calculation of invested capital, and changes in these components influence the overall trend.

Invested Capital Trend

Invested capital decreased from US$95,922 million in 2021 to US$61,356 million in 2025. The most significant decrease occurred between 2022 and 2023, falling from US$82,134 million to US$68,204 million. A smaller decrease was observed between 2021 and 2022. A slight increase occurred between 2023 and 2024, followed by a further decrease in 2025.

Debt & Leases

Total reported debt & leases decreased from US$77,575 million in 2021 to US$64,191 million in 2022, continuing to US$60,286 million in 2023. An increase to US$68,019 million was noted in 2024, followed by a marginal increase to US$68,379 million in 2025. While fluctuating, the level of debt remained relatively stable between 2024 and 2025.

Stockholders’ Equity

Stockholders’ equity increased from US$15,408 million in 2021 to US$17,254 million in 2022. However, a substantial decline was observed in subsequent years, decreasing to US$10,360 million in 2023, US$3,325 million in 2024, and ultimately reaching a deficit of US$-3,270 million in 2025. This negative equity position in the final year represents a significant shift.

The decrease in invested capital appears to be primarily driven by the substantial reduction in stockholders’ equity, particularly in the later years of the period. While debt levels decreased initially, they stabilized and even increased slightly in the most recent years, suggesting that debt reduction is not the primary driver of the overall decline in invested capital. The transition to negative stockholders’ equity in 2025 is a notable development that warrants further investigation.

The economic spread ratio exhibited considerable fluctuation over the five-year period. Initially positive, the ratio declined significantly, becoming negative before recovering in the final year. This movement correlates with changes in economic profit and invested capital.

Economic Spread Ratio Trend

The economic spread ratio began at 5.25% in 2021, increasing to a peak of 5.91% in 2022. A substantial decrease followed, with the ratio falling to -3.50% in 2023 and further to -1.79% in 2024. A positive value of 1.15% was recorded in 2025, indicating a return to value creation as measured by this metric.

The initial increase in the economic spread ratio in 2022 suggests improved profitability relative to invested capital. However, the subsequent and dramatic declines in 2023 and 2024 indicate that economic profit was insufficient to cover the cost of capital employed. The recovery in 2025 suggests a potential improvement in the relationship between economic profit and invested capital.

Relationship to Economic Profit

The economic spread ratio’s trajectory closely mirrors that of economic profit. The positive ratios in 2021 and 2022 correspond with positive economic profit figures. The negative ratios in 2023 and 2024 align with negative economic profit, demonstrating that when the company generated an economic loss, the spread ratio became negative.

Relationship to Invested Capital

Invested capital decreased consistently from 2021 to 2025. While decreasing invested capital can sometimes improve ratios, the substantial decline in economic profit overwhelmed this effect in 2023 and 2024, resulting in increasingly negative economic spread ratios. The final year’s positive spread ratio suggests that the combination of increased economic profit and continued reduction in invested capital contributed to the improvement.

The volatility in the economic spread ratio warrants further investigation into the underlying drivers of economic profit and invested capital. Understanding the reasons for the declines in economic profit in 2023 and 2024, and the subsequent recovery in 2025, is crucial for assessing the company’s long-term value creation potential.

The economic profit margin exhibited considerable fluctuation over the five-year period. Initially positive, it declined significantly before recovering towards the end of the analyzed timeframe. A detailed examination of the trends is presented below.

Economic Profit Margin Trend

In 2021, the economic profit margin stood at 8.96%. A slight decrease was observed in 2022, with the margin falling to 8.36%. However, 2023 marked a substantial shift, as the margin turned negative, reaching -4.40%. This negative trend continued into 2024, with the margin further declining to -2.20%. By 2025, the economic profit margin had begun to recover, increasing to 1.16%, though remaining relatively low compared to earlier years.

Relationship to Net Revenues

Net revenues generally increased over the period, rising from US$56,197 million in 2021 to US$61,160 million in 2025. Despite this revenue growth, the economic profit margin did not consistently benefit. The decline in margin from 2021 to 2024 suggests that increases in costs or capital charges outpaced revenue gains during those years. The partial recovery in margin in 2025 coincides with a continued increase in net revenues, indicating a potential stabilization of cost structures or capital efficiency.

Economic Profit Performance

Economic profit itself mirrored the trend in the economic profit margin. Positive economic profit of US$5,036 million and US$4,851 million was reported in 2021 and 2022, respectively. However, economic profit became negative in 2023 (US$-2,389 million) and 2024 (US$-1,239 million), before turning positive again in 2025, reaching US$708 million. This confirms the correlation between overall profitability and the economic profit margin.

The observed volatility in the economic profit margin warrants further investigation into the underlying drivers of profitability and capital efficiency. While revenue growth is evident, maintaining or improving the economic profit margin will likely require focused efforts on cost management and optimizing capital allocation.